ReciBioPharm is a prominent contract development and manufacturing organisation (CDMO) that partners with pharmaceutical companies to develop and manufacture complex biological drugs and innovative therapies. Founded in 2019, ReciBioPharm utilises a dedicated team and state-of-the-art facilities to advance products from development to commercial launch. The organisation focuses on expanding capacity and enhancing development and manufacturing services across multiple sites, employing advanced technology platforms to meet the evolving demands of its clients and partners.

Services include:
- Cell and Gene Therapy
- Process Development
- Analytical and Quality Control
- Clinical and Commercial Manufacturing
- Formulation Development

In conclusion, ReciBioPharm is committed to supporting the pharmaceutical industry by providing a wide range of services tailored to the needs of its clients. For more information, please visit arrantabio.com.